A Dual Topoisomerase Inhibitor of Intense Pro-Apoptotic and Antileukemic Nature for Cancer Treatment-Reference-Cited by-同舟云学术

A Dual Topoisomerase Inhibitor of Intense Pro-Apoptotic and Antileukemic Nature for Cancer Treatment

Published:2017-02-08 Issue:5 Volume:12 Page:347-352
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Meier Christopher¹,Steinhauer Tamara N.¹,Koczian Fabian²,Plitzko Birte¹,Jarolim Katharina³,Girreser Ulrich¹,Braig Simone²,Marko Doris³,Vollmar Angelika M.²,Clement Bernd¹

Affiliation:

1. Department of Pharmaceutical and Medicinal Chemistry; Pharmaceutical Institute of the Christian Albrechts University in Kiel; Gutenbergstraße 76 24118 Kiel Germany

2. Department of Pharmacy, Center for Drug Research; Pharmaceutical Biology; University of Munich; Butenandtstraße 5-13 81377 Munich Germany

3. Department of Food Chemistry and Toxicology; University of Vienna; Währinger Straße 38 1090 Vienna Austria

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference61 articles.

1. Dual topoisomerase I/II inhibitors

2. DNA Topoisomerases: Structure, Function, and Mechanism

3. Topoisomerase I inhibitors: camptothecins and beyond

4. Targeting DNA topoisomerase II in cancer chemotherapy

5. The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of 6-methylphenanthridines and evaluation against human papillomavirus-related endocervical adenocarcinoma (KB 3.1) cells;Phytochemistry Letters;2023-04

2. Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer;International Journal of Molecular Sciences;2022-09-10

3. High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer;Cancers;2021-12-21

4. The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In Vivo;Molecular Cancer Therapeutics;2021-11-01

5. In‐Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development;Angewandte Chemie International Edition;2021-10-05